inveox - About the company
inveox is a series A company based in Munich (Germany), founded in 2017 by Maria Driesel. It operates as a Manufacturing automated laboratory solutions for biopsy sample preparation. inveox has raised $25.8M in funding. The company has 109 active competitors, including 21 funded and 12 that have exited. Its top competitors include companies like Evosep, Prenuvo and IdentifySensors.
Company Details
Inveox offers automated laboratory solutions for biopsy samples (transferring and labeling tissue samples, sample receipt, and encapsulation of biopsy samples. The company provides software for lab information management and gets the digitally linked relevant information using a QR-code. The company has designed an automated device for sample processing, management, sample container arrangement, and more.
- Website
- inveox.com
- Email ID
- *****@inveox.com
- Phone Number
- +49 **********
- Registered Address
- inveox GmbH Lichtenbergstrasse 8 85748 Garching near Munich
Key Metrics
Founded Year
2017
Location
Munich, Germany
Stage
Series A
Total Funding
$25.8M in 5 rounds
Latest Funding Round
Investors
Ranked
12th among 109 active competitors
Employee Count
7 as on May 31, 2026
Legal entities associated with inveox
inveox is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Inveox Gmbh CIN: HRB231617. , Germany, Active | Feb 22, 2017 | - | - |
Sign up to download inveox's company profile
inveox's funding and investors
inveox has raised a total funding of $25.8M over 5 rounds. Its first funding round was on Jun 07, 2017. inveox has 8 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of inveox:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 05, 2019 | 2610643 | Series A | 5410381 | 2768917 | 2216993 | 5012534 |
Oct 05, 2018 | 2973874 | Grant (prize money) | 9799202 | 7590290 | 1274551 | |
Sep 04, 2018 | 7388158 | Angel | 8237868 | 8836439 | 7972642 | 4579055 |
View details of inveox's funding rounds and investors
inveox's founders and board of directors
Founder? Claim ProfileThe founders of inveox is Maria Driesel. Maria Driesel is the CEO of inveox.
Here are the details of inveox's key team members:
- Maria Driesel: Co-Founder & CEO of inveox. Contact Info: 1 email address
View details of inveox's Founder profiles and Board Members
inveox's employee count trend
inveox has 7 employees as of May 26. Here is inveox's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
inveox's Competitors and alternates
Top competitors of inveox include Evosep, Prenuvo and IdentifySensors. Here is the list of Top 10 competitors of inveox, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of solutions for clinical proteomics | $48.8M | 59/100 | ||
2nd | Prenuvo 2018, San Francisco (United States), Series C | Provider of MRI and other screening services | $275M | 57/100 | |
3rd | IdentifySensors 2006, Shaker Heights (United States), Series B | Provider of bio-sensors for real-time detection of materials and chemicals harmful to humans | $22.1M | - | 51/100 |
4th | Developer of a microfluidic-based technology called acoustofluidics | $214K | 48/100 | ||
5th | Nanovery 2018, London (United Kingdom), Seed | Developer of nanobots for diagnosing cancer | $7.32M | 47/100 | |
6th | Curiox 2007, Seoul (South Korea), Public | Developer of wall-less plates and washers for automated cell-based assays | $30M | 46/100 | |
7th | Developer of an imaging system for microscopes | $9.34M | 41/100 | ||
8th | Pressure BioSciences 1978, Easton (United States), Public | Platform technology to control biomolecular reactions | - | 44/100 | |
9th | C the Signs 2016, London (United Kingdom), Series A | Platform offering cancer prediction system for early cancer detection | $14.9M | 43/100 | |
10th | nRichDX 2016, Irvine (United States), Unfunded | Provider of the devices for liquid biopsy for molecular testing | - | - | 42/100 |
12th | Manufacturing automated laboratory solutions for biopsy sample preparation | $25.8M | 41/100 |
Looking for more details on inveox's competitors? Click here to see the top ones
inveox's Investments and acquisitions
inveox has made no investments or acquisitions yet.
Reports related to inveox
Here is the latest report on inveox's sector:
News related to inveox
•
•
Oval Medical Technologies Ltd and inveox GmbH choose Veeva MedTech to improve qualityPR Newswire•Jun 23, 2021•Veeva Systems, inveox
•
inveox Acquires Further Investment: 17 Million for Future Cancer DiagnosesSpotfolio•Aug 05, 2019•inveox, Imprimatur Capital, Techstart Ventures, Clarendon Fund Managers and 1 other
•
Are you a Founder ?
FAQs about inveox
Explore our recently published companies
- Vistello - Unfunded company
- PV Lumens - Mumbai based, 2012 founded, Unfunded company
- Blast Studio - London based, 2018 founded, Unfunded company
- Milk Road - Toronto based, 2022 founded, Unfunded company
- Enthela - Blagoevgrad based, 2023 founded, Unfunded company
- Altered Materials - Turin based, 2025 founded, Funding Raised company
_1530677562297.png?format=webp&height=120&width=120)